Navigation Links
Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
Date:6/15/2012

s or future diagnostic products, including the risk that its products will not be competitive with products offered by other companies, or that users will not be entitled to receive adequate reimbursement for its products from third party payors such as private insurance companies and government insurance plans; (5) uncertainty that Vermillion has sufficient cash resources to fully commercialize its tests and continue as a going concern; (6) uncertainty whether the trading in Vermillion's stock will become significantly less liquid; and (7) other factors that might be described from time to time in Vermillion's filings with the Securities and Exchange Commission. All information in this press release is as of the date of this report, and Vermillion expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Vermillion's expectations or any change in events, conditions or circumstances on which any such statement is based, unless required by law.

This release should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent reports on Form 10-K and Form 10-Q. Copies are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR) at www.sec.gov.

(1) National Institutes of Health Publication No. 06 5837

Investor Relations Contact:
Liolios Group, Inc.
Ron Both
Tel 949-574-3860
vrml@liolios.com


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vermillion Announces CEO Succession Plan
2. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
3. IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve womens health and prenatal care
4. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
5. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
6. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
7. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
8. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
9. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
10. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
11. Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral ... been enrolled in its Glucose Clamp Study. The study ... Science Center at San Antonio ... supervision of Professor Ralph DeFronzo . ...
(Date:4/1/2015)... , April 1, 2015  Boston Scientific Corporation (NYSE: ... April 28, 2015 at 8 a.m. ET to review financial ... company will issue a news release announcing first quarter financial ... will be hosted by Mike Mahoney , president and ... president and chief financial officer. A live webcast ...
(Date:4/1/2015)... WALNUT CREEK, Calif. , April 1, 2015 /PRNewswire/ ... a huge difference.  When this is the case, having ... changer.  No one understands this truth better than software ... test laboratory management software QATrax.  Recently, the company announced ... a very enthusiastic response from clients. ...
Breaking Medicine Technology:Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2
(Date:4/1/2015)... 2015 Tempaper has joined forces with ... giving campaign that will raise critical funds to help ... disease across the United States. , Throughout the month ... Tempaperdesigns.com will automatically receive free domestic ground shipping ... urgently needed progress to children and adults affected by ...
(Date:4/1/2015)... April 01, 2015 Like a mosaic ... the scientific understanding of the potential causes of rosacea. ... the National Rosacea Society (NRS) to educate the public ... facial disorder now estimated to affect more than 16 ... medical research on rosacea through its patient-funded research grants ...
(Date:4/1/2015)... Sunrise, FL (PRWEB) April 01, 2015 ... fastest growing health and nutritional supplement companies in the U.S., ... expand the testing and quality control standards for its herbal ... into the supply chain to ensure the accuracy of labeling ... news, industry veteran and IQ Formulations CEO Jay ...
(Date:4/1/2015)... 01, 2015 Health Advocate™, Inc., the ... subsidiary of West Corporation, today launched its new Health ... and through the Health Advocate member website, features ... and stay, healthy. , “We’re pleased to introduce this ... public,” said Martin Rosen, Executive Vice President, Health Advocate. ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 When annoying ... occur, waiting days or weeks for an appointment with ... same and next day appointments haven’t been possible within ... Forefront Dermatology’s offices have noticed demand for this level ... “We realize how important relief or answers to dermatological ...
Breaking Medicine News(10 mins):Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2
... is usually enough, but editorial begs to differ , TUESDAY, ... in a medical journal to be accompanied by an editorial ... "overly simple and consequently not clinically useful." , However, that ... of the Journal of the American Medical Association . ...
... WASHINGTON , Feb. 2 The following ... president of the Consumer Healthcare Products Association (CHPA), in response ... to access over-the-counter cold and allergy medicines containing pseudoephedrine: , ... to overlook consumer sentiment and passed a bill today that ...
... , WASHINGTON , Feb. ... — the nation,s largest nonpartisan individual membership association of state legislators ... Representatives Peggy Mast and Brenda Landwehr for ... right of individuals to make their own health care choices. Sen. ...
... scared parents over possible link between MMR vaccine, developmental ... The prestigious British medical journal The Lancet ... had linked the measles, mumps and rubella vaccine to ... on Feb. 28, 1998, set off a worldwide ...
... Donnelly,s classmates nicknamed her "Knobby" because she was so skinny ... skin. But when Donnelly turned 27, that once knobby frame ... was still walking several miles a day, but she gained ... the cause was ovarian cysts. It took ten years and ...
... require certain cancer surgeries can have the procedures performed ... to a new study. The research showed that ... gastric and colon, younger patients with few pre-existing illnesses ... as at cancer centers. But patients who are ...
Cached Medicine News:Health News:Analysis Examines Ultrasound Use for Blood Clots 2Health News:Analysis Examines Ultrasound Use for Blood Clots 3Health News:Statement from the Consumer Healthcare Products Association on Mississippi Bill that Limits Consumer Access to Cold and Allergy Medicines Containing Pseudoephedrine by Requiring a Prescription 2Health News:Kansas Legislators Stand for Health Care Freedom 2Health News:Kansas Legislators Stand for Health Care Freedom 3Health News:Controversial Autism Study Retracted by Medical Journal 2Health News:Controversial Autism Study Retracted by Medical Journal 3Health News:Controversial Autism Study Retracted by Medical Journal 4Health News:Doctors miss major cause of infertility and obesity 2Health News:Community hospitals offer a safe surgical option for some cancer surgeries 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: